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Summary
 
Signaling via the pre-T cell receptor (TCR) is required for the proliferative expansion and mat-
uration of CD4
 
2
 
CD8
 
2
 
 double-negative (DN) thymocytes into CD4
 
1
 
CD8
 
1
 
 double-positive
(DP) cells and for TCR-
 
b
 
 allelic exclusion. The adaptor protein SH2 domain–containing leu-
kocyte protein (SLP)-76 has been shown to play a crucial role in thymic development, because
thymocytes of SLP-76
 
2
 
/
 
2
 
 mice are arrested at the CD25
 
1
 
CD44
 
2
 
 DN stage. Here we show
that SLP-76
 
2
 
/
 
2
 
 DN thymocytes express the pre-TCR on their surfaces and that introduction
of a TCR-
 
a/b
 
 transgene into the SLP-76
 
2
 
/
 
2
 
 background fails to cause expansion of DN thymo-
cytes or developmental progression to the DP stage. Moreover, analysis of TCR-
 
b
 
 rearrange-
ment in SLP-76
 
2
 
/
 
2
 
 TCR-transgenic mice or in single CD25
 
1
 
CD44
 
2
 
 DN cells from SLP-76
 
2
 
/
 
2
 
mice indicates an essential role of SLP-76 in TCR-
 
b
 
 allelic exclusion.
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T
 
he pre-TCR controls the survival of CD4
 
2
 
CD8
 
2
 
double-negative (DN)
 
1
 
 thymocytes and their intense
proliferation and maturation into CD4
 
1
 
CD8
 
1
 
 double-pos-
itive (DP) thymocytes by mostly unknown mechanisms
(1). It is clear that this control requires the pre–TCR-
 
a
 
chain (pT
 
a
 
), the TCR-
 
b
 
 chain, signal-transducing mole-
cules of the CD3 complex, Src kinases, and Zap-70 and
Syk kinases (2–6). Some experiments suggest that exit from
the endoplasmic reticulum is essential for pre-TCR func-
tion (7), but other data have been interpreted to indicate
that binding to a ligand may not be an essential event (8).
In fact, surface expression of the pre-TCR on the CD25
 
1
 
CD44
 
2
 
 population of thymocytes that require the pre-
TCR for further maturation has not been well docu-
mented. It is also not clear whether the function of the pre-
TCR includes mainly rescue from cell death, allowing an
already imprinted program of expansion and maturation to
take place, or whether the pre-TCR directly controls cell
cycle progression as well as expression of genes encoding
various cell surface molecules. Experiments addressing this
question have given conflicting results, as in bcl-2–trans-
genic SCID mice, antiapoptotic bcl-2–dependent signals
were insufficient to permit developmental changes, whereas
overexpression of bcl-2 in DN thymocytes of recombina-
tion activating gene (RAG)
 
2
 
/
 
2
 
 mice promoted differentia-
tion to the CD4
 
1
 
CD8
 
1
 
 DP stage (9, 10).
Another event associated with pre-TCR signaling is the
allelic exclusion of the TCR-
 
b
 
 locus, i.e., the feedback in-
hibition of the rearrangement on one allele by the TCR-
 
b
 
protein encoded by the other allele. Effective allelic exclu-
sion as it is observed in 
 
a
 
/
 
b
 
 T cells requires not only this
feedback inhibition but also asynchronous V
 
b
 
 rearrange-
ment on the two alleles (11). Direct analysis of TCR-
 
b
 
 re-
arrangement in single cells at the CD25
 
1
 
44
 
2
 
 stage of de-
velopment, i.e., before selection by the pre-TCR, has
shown that the pre-TCR has an essential function in this
process (12). Although these data were obtained by single-
cell PCR analysis in pT
 
a
 
2
 
/
 
2 
 
mice, experiments in TCR-
 
b
 
–transgenic mice have shown that TCR-
 
b
 
 transgenes can
inhibit V
 
b
 
 rearrangement in the absence of the pT
 
a
 
 pro-
tein, most likely because of their high and early expression
(13). Whatever the mechanism of this suppression, it also
appears to depend on signals transduced via CD3, because
it is not operative in CD3
 
e
 
-deficient mice (14).
Experiments in mice expressing active p56
 
lck
 
 indicate that
Src kinases are also involved in TCR-
 
b
 
 allelic exclusion, as
V
 
b
 
 rearrangement is inhibited in such mice (15). Recent
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DN, double-negative; DP, double-posi-
tive; RAG, recombination activating gene; SLP, SH2 domain–containing
leukocyte protein; WT, wild-type.  
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2
 
/
 
2
 
 Mice
 
data, however, suggest that TCR-
 
b
 
 allelic exclusion may re-
quire signaling pathways that are distinct from signals con-
trolling proliferation and maturation, indicating that the
pre-TCR has functions in addition to those responsible for
rescue from programmed cell death. Active Ras, known to
activate the mitogen-activated protein kinase pathway, was
shown to drive proliferation and maturation in immature
thymocytes but, in contrast to active p56
 
lck
 
, failed to suppress
TCR-
 
b
 
 rearrangement (16). This means that some bifurca-
tion of signal transduction pathways downstream of p56
 
lck
 
is responsible for proliferation and maturation on the one
hand and allelic exclusion on the other.
Recently, it has been shown that the adaptor protein SH2
domain–containing leukocyte protein (SLP)-76 is involved
in several distinct signaling pathways and represents an es-
sential component in the signaling cascade that is involved
in the proliferation and maturation of 
 
a
 
/
 
b
 
 T cells (17, 18).
Although SLP-76 lacks intrinsic enzymatic activity, it facil-
itates through its tyrosine phosphorylation the propagation
of signals emanating from the TCR (19). Biochemical
characterization reveals three domains in SLP-76 that direct
intramolecular interactions with Zap-70, Vav, Grb2, SLP-
76–associated phosphoprotein, 130 kD (SLAP-130), and
other proteins (20). Overexpression of SLP-76 augments
TCR-mediated IL-2 transcription (21), whereas extinction
of SLP-76 expression in a mutant variant of the Jurkat T
cell line leads to attenuated calcium mobilization and mito-
gen-activated protein kinase activation (22). Furthermore,
mice deficient in SLP-76 demonstrate a total block in early
T cell development, implicating the SLP-76 linker protein in
the pre-TCR signaling cascade (17, 18). Here we have an-
alyzed the role of SLP-76 in the regulation of expression of
the TCR-
 
b
 
 locus as well as in TCR-
 
b
 
 allelic exclusion. Our
results indicate that SLP-76 has an essential role in all known
phenotypic changes that are mediated by the pre-TCR.
 
Materials and Methods
 
Cells, Antibodies, and Flow Cytometric Analysis.
 
The SCB29 cell
line, which expresses the pre-TCR on the cell surface, was de-
scribed previously (23). Single-cell suspensions from thymi were
prepared by compression between ground glass slides followed by
centrifugation on a density gradient of Lympholyte-M (Cedarlane
Labs., Inc.). Streptavidin–Cy-Chrome, streptavidin–PE, and mAbs
to the following mouse antigens were purchased from PharMingen:
CD3
 
e
 
 (clone 145-2C11), CD4 (L3T4), CD8
 
a
 
 (53-6.7), CD25
(7D4), CD44 (IM7), Thy1.2 (53-2.1), Mac-1 (M1/70), Gr-1
(RB6-8C5), and TCR-
 
b
 
 (H57-597). Anti-CD25 mAb (3C7)
conjugated to PE and anti-CD44 mAb conjugated to FITC were
purchased from Sigma Chemical Co. Anti-pT
 
a
 
 mAb 2F5 was
raised against the extracellular (Ig-like) domain as described pre-
viously (24). In the case of pre-TCR surface detection, thymo-
cytes were enriched for the CD4
 
2
 
CD8
 
2
 
 subset by depletion of
CD4/CD8-positive cells using Dynabeads (Dynal). pT
 
a
 
 (2F5) and
TCR-
 
b
 
 (H-57) biotinylated antibodies were revealed with strepta-
vidin–PBXL-3 (Martek Biosciences). NK and NK-T cells were
gated out with DX-5, NK1.1, or 2B4 antibodies (PharMingen).
Cytoplasmic staining for TCR-
 
b
 
 was performed as previously
described (25). Cells were surface stained and analyzed on a FACS-
Calibur™ flow cytometer (Becton Dickinson) as previously de-
 
scribed (26). Intracellular staining for TCR-
 
b
 
 was performed on
CD25
 
1
 
 sorted cells as previously described (12). Data on 5 
 
3
 
 10
 
5
 
–
2.0 
 
3
 
 10
 
6
 
 viable, nonerythroid cells (as determined by forward ver-
sus side scatter) were collected for each sample. FACS™ analysis was
performed on cells from groups of at least three mice aged 2–4 wk.
 
Generation of SLP-76
 
2
 
/
 
2
 
 TCR-
 
a/b
 
–transgenic Mice.
 
The gener-
ation of TCR-
 
a
 
2
 
/
 
2
 
, pT
 
a
 
2
 
/
 
2
 
, RAG-2
 
2
 
/
 
2
 
, and SLP-76
 
2
 
/
 
2
 
 mice
was previously described (2, 4, 17, 27). Mice transgenic for the
TCRV
 
a
 
13 and TCRV
 
b
 
8.2 chains of the OVA-specific mouse T
cell hybridoma DO11.10 were a gift of Dr. Dennis Loh (Hoffmann-
LaRoche, Inc., Nutley, NJ; reference 28). Screening for expression
of the transgenic TCR was done by PCR analysis of tail DNA, us-
ing primer sequences provided by Dr. K. Murphy (Washington
University, St. Louis, MO), and by FACS™ analysis, using the anti-
idiotypic mAb KJ126, provided by Dr. K. Murphy. Screening for
disruption of the 
 
SLP-76
 
 gene was done as previously described (17).
 
PCR Analysis of TCR-
 
b
 
 Gene Rearrangements in Thymocytes.
 
Genomic DNA was isolated according to published procedures
(29). V
 
b
 
 to DJ
 
b
 
 rearrangements were assessed as described in de-
tail in reference 16. In brief, upstream primers were located on the
V
 
b
 
 segments 5, 8, and 10, and the downstream primer was located
3
 
9
 
 of J
 
b
 
2.7. After amplification of the rearrangements by PCR,
the products were separated on agarose gels, transferred to nylon
membranes, and hybridized with a J
 
b
 
2.7-specific, 
 
32
 
P-labeled oligo-
nucleotide probe. Hybridizing bands were scanned using a Phos-
phorImager (Molecular Dynamics). Amplification of a fragment
of the nonrearranging C
 
m gene served as a loading control.
Single-Cell PCR. TCR-b1
icCD251 small single cells from
SLP-762/2 mice were sorted using a FACSVantage™ equipped
with an automatic cell deposition unit (Becton Dickinson). DNA
from single cells was prepared as previously described (12). TCR-b
gene rearrangements were amplified by a seminested two-step
PCR protocol (12, 30). In the first step, both alleles were ampli-
fied simultaneously by addition to each tube of 35 ml of a mixture
containing dNTPs, buffer, and Taq polymerase at 0.5 U/sample
(Perkin-Elmer Corp.). 18 59 primers (3 pmol of each) homologous
to 16 Vb gene families and Db1 and Db2 genes, and 2 39 primers
(3 pmol of each) that primed downstream of the Jb1 and Jb2 clus-
ter sequences, respectively, were used (12). In addition to the
previously described primers, 59 primers specific for Vb3 (59-ACG-
ATTCTCTGCTGAGTGTCCTCC-39), Vb9 (59-GAACAGG-
GAAGCTGACACTTTTGAG-39), and Vb17 (59-GTCCTGA-
AAAAGGGCACACTGCCT-39) were used. The first round of
amplification was performed in a final volume of 60 ml for five
cycles, in which the annealing temperature decreased from 68 to
608C, followed by 25 cycles of amplification (30 s at 948C, 1 min
at 588C, 1 min at 728C), and finally 5 min at 728C. For the sec-
ond round of amplification, 1 ml of the first PCR product was
transferred into separate tubes, each containing a single 59 primer
in combination with the nested Jb2 or Jb1 39 primer (10 pmol of
each), dNTP, reaction buffer, and 1 U of Taq polymerase in a final
volume of 20 ml. Amplification was then carried out for 35 cycles,
following the procedure of the first PCR. Vb and Jb were iden-
tified by migration of the total PCR product on a 1.5% ethidium
bromide–stained agarose gel, and positives were purified using
Geneclean III (Bio 101). Direct sequencing of the PCR products
was performed using the Ready Reaction DyeDeoxy Terminator
Cycle sequencing kit (Applied Biosystems, Inc.) and sequenced
by automated sequencing (Applied Biosystems, Inc.).
Results
The Pre-TCR Is Expressed on the Surfaces of SLP-762/2
Thymocytes. Surface expression of the pre-TCR is required1095 Aifantis et al.
for TCR-b allelic exclusion (for review see reference 31).
In the analysis of allelic exclusion in SLP-762/2 mice, it was
therefore important to ascertain expression of the pre-TCR
by SLP-76–deficient thymocytes. In previous experiments,
we have detected low levels of expression of CD3 and
TCR-b on SLP-762/2CD42CD82 DN thymocytes, sug-
gesting that the pre-TCR is expressed on the cell surfaces
of these immature thymocytes (17). To extend these obser-
vations, we repeated these experiments with a fluorochrome
reagent, streptavidin–PBXL-3 (Martek Biosciences), that
gives much higher signal intensity than conventional reagents
(i.e., streptavidin–FITC or –APC) when used in combination
with biotinylated antibodies. This can be clearly seen by
staining the SCB29 cell line, which expresses the pre-TCR
on the cell surface (23), with biotinylated mAb to TCR-b
(H57) or pTa (2F5), followed by incubation with either
streptavidin–FITC or –PBXL-3 (Fig. 1). Incubation with
irrelevant mAbs of the same Ig class produces some slight
background that, however, is clearly distinct from the
staining obtained with antibodies specific for cell surface–
expressed proteins (Fig. 1).
In subsequent experiments, CD42CD82 DN thymocytes
from wild-type (WT), TCR-a2/2, SLP-762/2, pTa2/2,
and RAG-22/2 mice were examined for TCR-b and pTa
expression. Thymocyte development in SLP-762/2 mice is
blocked at the stage of CD251CD442 DN cells. CD252
CD442 cells, which represent a more mature stage of DN
thymocytes, are absent in SLP-762/2 mice (17). We therefore
focused our analysis on CD251CD442 DN cells. DN thymo-
cytes were stained with directly labeled antibodies against
CD44 and CD25, as well as biotinylated antibodies against
either TCR-b or pTa followed by streptavidin–PBXL-3, and
gated populations of CD251CD442 cells were analyzed for
TCR-b and pTa expression. The histograms in Fig. 2 show
Figure 1. Pre-TCR expression on the surface of the SCB29 cell line
and comparison of the labeling intensity between streptavidin–PBXL-3
and streptavidin–FITC. SCB29 cells were initially incubated with biotin-
ylated 2F5 (pTa) and H57 (pan-TCR-a/b) antibodies (thick line) or iso-
type-matched controls (thin line), and surface expression was revealed by
streptavidin conjugated to the secondary reagents. Similar results were
obtained in two other experiments.
Figure 2. Expression of the
pre-TCR complex on the sur-
faces of CD251CD442 CD42
CD82 DN thymocytes from
RAG-22/2, pTa2/2, TCR-a2/2,
and SLP-762/2 mice. CD41 and
CD81 thymocytes and NK cells
were depleted with Dynabeads,
and DN cells were stained with
CD25, CD44, 2.4G2 (Fc-block),
H57 (TCR-b), or 2F5 (pTa) an-
tibodies. Analysis of gated CD251
CD442 cells is shown. Results are
representative of three mice in
each group.1096 Allelic Exclusion in SLP-762/2 Mice
that, as expected, mAb to TCR-b did not stain thymocytes
from RAG-22/2 mice and mAb to pTa did not stain thy-
mocytes from pTa2/2 mice when compared with control
antibodies. This further confirms the specificity of the stain-
ing. There was negligible, if any, staining of RAG-22/2 thy-
mocytes with anti-pTa mAb or of pTa2/2 thymocytes with
anti–TCR-b mAb. CD251CD442 DN thymocytes from
SLP-762/2 mice stained with both antibodies to the same
or slightly higher level as CD251 CD442 DN cells from
TCR-a2/2 mice (Fig. 2). DN thymocytes from TCR-a2/2
mice were used as controls to eliminate the possibility of
staining TCR-b proteins that are transported to the cell
surface as a/b TCRs. The surface expression of TCR-b and
pTa chains on CD251CD442 as well as CD252CD442
thymocytes from TCR-a2/2 mice and WT controls was
identical (data not shown).
We next examined intracellular TCR-b protein expres-
sion in SLP-762/2 thymocytes. Fig. 3 shows that SLP-76–
deficient CD251 thymocytes expressed lower levels of intra-
cellular TCR-b protein than WT CD251 thymocytes (Fig.
3). Decreased levels of expression of intracellular TCR-b
protein were also observed in CD251 thymocytes from
pTa2/2 mice, which are also blocked at the CD251CD442
DN stage (2). The CD252TCR-b1 cells in SLP-762/2 mice
may represent g/d cells that express cytoplasmic TCR-b
chain, as has been shown recently in pTa2/2 mice (32).
These results suggest that SLP-76 is not required for assem-
bly and surface expression of TCR-b chains. However, it is
required for the generation of CD251 DN cells that ex-
press high levels of TCR-b protein intracellularly.
Introduction of TCR-a/b Transgenes Does Not Overcome the
Block in Thymic Development in SLP-762/2 Mice. Introduc-
tion of a TCR-b transgene into SCID or RAG-deficient
mice drives the development of DN thymocytes into DP cells
(33, 34). To examine the effect of introduction of TCR
transgenes on thymic development in SLP-762/2 mice,
they were bred with mice transgenic for the TCRVa13
and TCRVb8.2 chains of the OVA-specific mouse T cell
hybridoma DO11.10. The transgenes are concordantly ex-
pressed early in thymocyte development at the DN stage
(28), and their introduction into a RAG-deficient back-
ground drives T cell development to the DN and single-
positive stage (33, 34). SLP-762/2 TCR-a/b–transgenic
(SLP-762/2-tg) F2 mice were identified by PCR analysis
of tail DNA.
The effect of introduction of the DO11.10 TCR-a/b
transgenes on thymic development in SLP-762/2 mice was
assessed by examining the thymi of SLP-762/2-tg mice for
cellularity, expression of CD3, TCR-b, CD4, and CD8, and
distribution of CD251 and CD441 DN subsets. As previ-
ously described, thymic cellularity in SLP-762/2 mice was
severely reduced to z1% of that of heterozygous litter-
mates, and there were no detectable DP nor single-positive
thymocytes (17). Introduction of the transgenic TCR into
the SLP-762/2 background did not increase thymic cellu-
larity (1.30 6 0.18 3 106 cells in SLP-762/2-tg mice versus
1.62 6 0.75 3 106 cells in SLP-762/2 mice; n 5 4 in each
group), but resulted in an increase in CD31TCR-b1 thy-
mocytes, consistent with surface expression of the transgene
(Fig. 4 A). The transition from DN to DP cells remained
severely impaired, as we could detect no or very few DP
thymocytes in SLP-762/2-tg mice (Fig. 4 B). Analysis of the
B2202Mac-12Gr-12CD32CD42CD82 DN compartment
for the expression of CD25 and CD44 revealed that intro-
duction of the transgenic TCR failed to overcome the
block in thymic development at the CD251CD442 stage
present in SLP-762/2 mice (Fig. 4 C). These results suggest
that the failure of DN cells from SLP-762/2 mice to
progress to the DP stage is due to deficient SLP-76–medi-
ated signaling and cannot be overcome by surface expres-
sion of the transgenic TCR.
Introduction of a TCR-a/b Transgene Does Not Inhibit En-
dogenous Rearrangement at the TCR-b Locus in SLP-762/2
Mice. Having established that the pre-TCR is expressed
on DN thymocytes from SLP-762/2 mice, we proceeded
to address the issue of whether TCR-b allelic exclusion
takes place in the absence of SLP-76. There are two ways
in which feedback inhibition by the pre-TCR resulting in
TCR-b allelic exclusion has been analyzed: one is the inhi-
Figure 3. Intracellular TCR-b expression in CD42CD82 DN cells
from WT (B6), pTa2/2, and SLP-762/2 mice. DN cells were surface
stained for CD25 and subsequently cytoplasmically labeled with TCR-b
antibodies. Results are representative of three mice in each group.1097 Aifantis et al.
bition of endogenous Vb rearrangements by TCR-b trans-
genes, and the other is the analysis of both TCR-b alleles
in single cells. We initially examined inhibition of Vb rear-
rangements by TCR transgenes.
In normal thymocytes, introduction of functionally rear-
ranged TCR-b transgenes leads to inhibition of rearrange-
ments in the endogenous TCR-b locus at the V to DJ step
(35). Furthermore, introduction of a TCR-b transgene in
pTa2/2 and p56lck2/2 also leads to inhibition of endogenous
TCR-b rearrangements (13, 36). To examine if introduc-
tion of the transgenic TCR into SLP-76–deficient thymo-
cytes could also inhibit endogenous Vb to DJb rearrange-
ments, we used a semiquantitative PCR assay as previously
described (16, 37). In these experiments, Vb to DJb2 rear-
rangements involving representative Vb segments (Vb5,
Vb8, and Vb10) were amplified from genomic DNA sam-
ples isolated from DN thymocytes of TCR-transgenic or
nontransgenic SLP-761/2 or SLP-762/2 mice. The identity
of the resulting DNA fragments corresponding to rearrange-
ments between a particular Vb and one of the Jb segments
was confirmed by Southern blot analysis with a Jb2.7-specific
probe. In agreement with our previously published obser-
vations (17), Vb to DJb rearrangements were readily detect-
able in both SLP-761/2 and SLP-762/2 thymocytes (Fig. 5,
lanes 1, 3, 5, 7, 9, and 11). As expected, introduction of the
TCR-a/b transgene into SLP-761/2 thymocytes almost com-
pletely blocked Vb to DJb rearrangements of the endogenous
TCR-b genes (Fig. 5, lanes 1, 2, 5, 6, 9, and 10). In contrast,
rearrangements of the endogenous TCR-b genes occurred
at comparable levels in both TCR-transgenic and nontrans-
genic SLP-762/2 thymocytes (Fig. 5, lanes 3, 4, 7, 8, 11, and
12). These results suggest that SLP-76 is essential for trans-
gene-mediated inhibition of TCR-b locus rearrangement.
The SLP-76 Adaptor Protein Is Required for TCR-b Allelic
Exclusion. Introduction of a TCR-b transgene into pTa2/2
mice (13) inhibits rearrangements of endogenous Vb seg-
ments, although single-cell PCR analysis of Vb rearrange-
ments reveals a failure of TCR-b allelic exclusion in pTa2/2
mice (12). This suggests that expression of the transgene
provides signals for inhibition of TCR-b rearrangement
that differ quantitatively and/or qualitatively from physio-
logic signals delivered via the pre-TCR and may not reflect
authentic allelic exclusion. To assess the status of TCR-b
allelic exclusion in unmanipulated SLP-762/2 mice, we ex-
Figure 4. Flow cytometric analysis of thymocytes from TCR-transgenic SLP-762/2 and SLP-761/2 littermates. Surface expression on thymocytes of
(A) CD3 (anti-CD3e–PE) versus TCR-b (anti–TCR-b–FITC), (B) CD4 (anti-CD4–FITC) versus CD8 (anti-CD8–PE), and (C) CD44 and CD25 on
DN thymocytes from SLP-762/2 and SLP-761/2 littermates. Cells were triple stained with anti-CD44–FITC, anti-CD25–PE, and a cocktail of biotin-
conjugated mAbs to CD3, CD4, CD8, B220, Mac-1, and Gr-1, followed by streptavidin–Cy-Chrome. Analysis was performed on gated Cy-Chrome–
negative cells. The percentage of cells found in each quadrant is indicated. In all FACS™ analyses, results from SLP-761/2 and WT mice were similar.
Therefore, only data of SLP-761/2 mice is shown. Results are representative of four mice examined in each group.1098 Allelic Exclusion in SLP-762/2 Mice
amined Vb rearrangements in single CD251CD442 thy-
mocytes from these mice.
In WT mice, only z40% of CD251TCR-b1 thymo-
cytes rearrange Vb on both alleles due to the feedback in-
hibition by the first productively rearranged allele that pre-
vents further rearrangement on the other allele (12). In
pTa2/2 mice, this feedback inhibition fails, and hence a
greater population of cells (60%) exhibits two completely
rearranged VDJb alleles (12). When single CD251CD442
DN cells from SLP-762/2 mice that expressed cytoplasmic
TCR-b chains were sorted and analyzed, a similar propor-
tion of the cells (60%) was found to contain rearranged
VDJb on both alleles (Table I).
T cells with two productive Vb rearrangements are a
rare event in WT mice; ,5% of normal cells with two Vb
rearrangements contain two productive alleles (12). When
the alleles from SLP-762/2 thymocytes with two Vb rear-
rangements were sequenced, it was found that 31% of the
cells with two Vb rearrangements had two productive al-
leles (Table I). The Vb usage and the sequences of the two
in-frame alleles are shown in Tables II and III. They pro-
vide no indication for the selection of certain Vb alleles in
allelically included cells, even though it is difficult to en-
tirely rule out this possibility due to the relatively small
sample size. Taken together, the data obtained by the sin-
gle-cell PCR analysis indicates that allelic exclusion at the
TCR-b locus requires the SLP-76 adaptor protein.
Discussion
The results of this study indicate that the adaptor protein
SLP-76 is not only essential for thymocyte expansion and
maturation from the DN to the DP stage but is also essen-
tial for TCR-b allelic exclusion. Despite expression of sur-
face pre-TCR, thymocytes from SLP-762/2 mice, which
are blocked at the CD251CD442 DN stage, failed to ex-
hibit TCR-b allelic exclusion, as evidenced by single-cell
PCR. Neither the defect in the feedback inhibition of en-
dogenous TCR-b locus rearrangements nor the block in
thymic development could be overcome by introduction
of a functional TCR-a/b transgene.
We have ascertained that CD251CD442 DN thymocytes
from SLP-762/2 as well as WT mice express the pTa and
TCR-b chains of the pre-TCR complex (Fig. 2). As the 2F5
antibody we used is directed against the extracellular Ig-like
domain of pTa, it is also clear from our studies that it is the
form of pTa that expresses the extracellular Ig-like domain
that reaches the cell surface. DN thymocytes from SLP-762/2
mice expressed equal or slightly higher amounts of TCR-b
chains on their surfaces compared with TCR-a2/2 (Fig. 2)
or WT mice (data not shown). The fact that DN thymocytes
from both SLP-762/2 and pTa2/2 mice express lesser
amounts of intracellular TCR-b chains than WT mice raises
the possibility that signals through the pre-TCR mediated by
SLP-76 may be important in upregulating TCR-b chain ex-
pression. The presence of a very small population of CD252
TCR-b1 DN thymocytes in SLP-762/2 thymocytes (z2%)
is consistent with the presence of a very small population of
CD252CD442 triple-negative cells in these mice (1.2%; Fig.
4 C). The equal or slightly higher surface expression of
TCR-b and pTa in SLP-762/2CD251 CD442 DN thymo-
cytes may then be accounted for by the developmental arrest
that results in the accumulation of small, noncycling CD251
CD442 DN cells, allowing these cells to bring a relatively
higher amount of the pre-TCR to the cell surface. Alterna-
tively, in the absence of SLP-76, internalization and subsequent
degradation of the pre-TCR, which is dependent on activation
of serine/threonine and tyrosine kinases (38), may be retarded.
Figure 5. Thymocytes from TCR-a/b–transgenic SLP-762/2 mice fail
to suppress V to DJ rearrangements in the endogenous TCR-b locus.
20 ng of genomic DNA isolated from DN thymocytes of SLP-761/2,
SLP-761/2-tg, SLP-762/2, and SLP-762/2-tg was amplified with primers
that specifically detect rearrangements among Vb5, Vb8, Vb10, and
DJb2. Equivalent loading was confirmed by amplification of a fragment
of the Cm gene (IgM). The PCR products were separated on a 1.5%
agarose gel, transferred to a nylon membrane, and hybridized with radio-
labeled oligonucleotide probes specific for Jb2.7 and Cm. For each Vb,
there are six bands that correspond to rearrangements to the DJb2 seg-
ments DJb2.1 through DJb2.7 (Jb2.6 is a pseudogene and is not rear-
ranged). Similar results were obtained in two other experiments.
Table I. Number of CD251442 Thymocytes from SLP-762/2 
Mice According to the Type of Rearrangements on Both TCR-b Alleles
Type of rearrangement
V(D)J/DJ* V(D)J/V(D)J* V(D)J1/V(D)J1‡ V(D)J1/V(D)J2‡
18 (40%) 27 (60%) 8 (31%) 18 (69%)
*Total cells 5 45.
‡TCR-b rearrangements were analyzed by PCR and subsequent mi-
gration of the products on an ethidium bromide–stained agarose gel.
Each V(D)J joint was determined by sequence analysis. V(D)J1 and
V(D)J2 correspond to productive and nonproductive rearrangements,
respectively. 26 VDJ/VDJ cells were sequenced.1099 Aifantis et al.
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.1100 Allelic Exclusion in SLP-762/2 Mice
Introduction of TCR-b transgenes into rearrangement-
deficient mice drives proliferative expansion and differenti-
ation of DN to DP cells (33, 34). In contrast, introduction
of functional TCR-b transgenes into SLP-762/2 mice
failed to increase thymic cellularity and failed to overcome
the block in the development of CD252CD442 DN cells
and in the transition from DN to DP cells (Fig. 4). We had
previously shown that treatment of SLP-762/2 mice with
anti-CD3e mAb induced the appearance of only a few DP
thymocytes (17), suggesting that an SLP-76–independent
pathway for DN to DP transition may exist. Such a pathway
could involve linker for activation of T cells (LAT)-Grb2-
Sos–mediated activation of Ras, as a transgene encoding an
active form of Ras (RasV12) has been shown to drive the de-
velopment of DP cells in the RAG2/2 background (39). It
appears from our data that expression of a transgenic TCR
may not be sufficient to activate an SLP-76–independent
pathway of thymocyte maturation.
Introduction of TCR-a/b transgenes into the SLP-76
background failed to suppress endogenous TCR-b rear-
rangement (Fig. 5). It has been suggested that inhibition of
endogenous TCR-b rearrangement by TCR-b transgenes
in pTa2/2 mice might be artifactual and might reflect acti-
vation of downstream pathways not ordinarily engaged by
the endogenous pre-TCR (12). Indeed, whereas introduc-
tion of a TCR-b transgene into the pTa2/2 background
shuts off endogenous TCR-b rearrangement, single-cell
analysis in pTa2/2 mice reveals failure of TCR-b allelic
exclusion (12, 13). As introduction of TCR-b transgenes
into pTa2/2 mice also drives the maturation of DN cells
into DP cells and their proliferation, premature transgene-
generated signals might accelerate development of normal
cells through stages at which the endogenous TCR-b genes
are assembled, leading to a block in rearrangement (40).
The failure of TCR-a/b transgenes to suppress endogenous
TCR-b rearrangement and induce maturation and expan-
sion of DN cells in SLP-762/2 mice suggests that trans-
gene-generated signals that lead to maturation and expan-
sion of DN cells and to feedback inhibition of endogenous
TCR-b rearrangement are strictly dependent on SLP-76.
Normally, 60% of surviving thymocytes carry only a sin-
gle Vb to DJb rearrangement, whereas the remaining 40%
carry one nonproductive and one productive Vb to DJb
rearrangement (35). The presence of .40% of cells with
Vb to DJb rearrangement on both alleles indicates a viola-
tion of TCR-b allelic exclusion. Single-cell PCR analysis
revealed that 60% of CD251CD442TCR-b1 DN thy-
mocytes from SLP-762/2 mice have undergone Vb to DJb
rearrangement on both TCR-b alleles (Table I). This indi-
cates that TCR-b allelic exclusion is defective in the ab-
sence of SLP-76 and suggests that SLP-76 is essential for
the transduction of the physiologic pre-TCR signal that in-
hibits V to DJ rearrangement on the second TCR-b allele.
Due to feedback inhibition of TCR-b locus rearrangement
by a productively rearranged allele (41), ,3% of normal T
cells carry two productive Vb gene rearrangements (12). In
the absence of feedback inhibition, it is expected that in 20%
of cells that rearrange two alleles, both alleles are rearranged
productively. When the alleles from SLP-762/2 thymocytes
with two Vb rearrangements were sequenced, it was found
that in 31% of the cells, both rearrangements were productive,
i.e., in frame (Table I). This is almost exactly the same per-
centage that was found in pTa2/2 mice (12). The discrepancy
between the observed and the predicted fraction of cells with
two productive Vb rearrangements may be due to selection
against cells that make a productive rearrangement on the sec-
ond allele only, due to lower TCR-b staining intensity, when
cells are sorted for expression of cytoplasmic TCR-b chains.
There was no indication for the selection of specific Vb alleles
in allelically included cells in either SLP-762/2 mice (Tables II
and III) or pTa2/2 mice (12). The presence of a significant
proportion of SLP-762/2 thymocytes with two productively
rearranged TCR-b alleles documents an essential role of
SLP-76 in allelic exclusion at the TCR-b locus. The fact
that similar percentages of cells with two in-frame alleles
were found in SLP-762/2 and pTa2/2 mice suggests that
the pre-TCR is the most important receptor that mediates
feedback inhibition of Vb rearrangement under physiolog-
ical conditions.
Table III. Characterization of TCR-b Rearrangements on
Both Alleles of CD251CD442 Thymocytes Obtained from
SLP-762/2 Mice
Code* Rearrangement Code Rearrangement
10 V15J2/D1J1 34 V11J2/V4J2
4 V16J1/D2J2 39 V8J1/V1J2
15 V11J1/D2J2 40 V4J2/V10J
29 V5J1/D2J2 49 V10J2/V15J1
41 V4J2/D1JI 54 V12J2/V4J2
43 V1J1/D2J2 62 V11J2/V1J1
45 V8J2/D1J1 64 V12J2/V10J2
47 V14J1/D1J1 65 V8J1/V12J1
52 V1J2/D1J2 69 V5J2/V17J2
58 V3J1/D1J2 74 V1J2/V5J2
68 V14J1/D1J2 76 V1J2/V5J2
73 V8J2/D1J2 93 V15J1/V14J2
79 V8J2/D1J2 97 V1J1/V10J1
87 V4J1/D2J2 104 V8J1/V5J1
100 V6J1/D2J2 114 V1J2/V8J2
103 V8J2/D2J2 118 V1J2/V6J2
119 V5J2/D1J1 120 V5J2/V10J2
134 V11J2/D1J1 131 V8J1/V5J2
94 V5J2/V15J2 138 V10J2/V15J1
7 V3J1/V17J2 141 V7J2/V1J1
11 V8J2/V2J1 143 V8J2/V11J2
19 V8J2/V4J2 2 V2J2/V9J2
32 V7J1/V12J2
*A number code was assigned to the CD251442TCR-b1 cells isolated
from SLP-762/2 mice. Data shown represent arrangements of Vb(Db)
or Db with the Jb cluster of genes.1101 Aifantis et al.
Recent data suggests that activation of Ras results in dif-
ferentiation and expansion of DN thymocytes but not in
TCR-b allelic exclusion (16). Thus, suppression of TCR-b
gene rearrangements appears to require the activity of an
additional and/or complementary pathway. As SLP-762/2
thymocytes are arrested at the DN stage and also fail to
suppress endogenous Vb to DJb rearrangements, even after
introduction of TCR-a/b transgenes, SLP-76 is likely to
be critical for TCR-mediated activation of both Ras-depen-
dent and Ras-independent pathways.
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